These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 36451573)

  • 21. Optimization of Pramipexole-Loaded In Situ Thermosensitive Intranasal Gel for Parkinson's Disease.
    Trivedi R; Minglani VV; El-Gazzar AM; Batiha GE; Mahmoud MH; Patel M; Patel M
    Pharmaceuticals (Basel); 2024 Jan; 17(2):. PubMed ID: 38399387
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The prescription design and key properties of nasal gel for CNS drug delivery: A review.
    Wang M; Ma X; Zong S; Su Y; Su R; Zhang H; Liu Y; Wang C; Li Y
    Eur J Pharm Sci; 2024 Jan; 192():106623. PubMed ID: 37890640
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacotechnical Development of a Nasal Drug Delivery Composite Nanosystem Intended for Alzheimer's Disease Treatment.
    Adnet T; Groo AC; Picard C; Davis A; Corvaisier S; Since M; Bounoure F; Rochais C; Pluart LL; Dallemagne P; Malzert-Fréon A
    Pharmaceutics; 2020 Mar; 12(3):. PubMed ID: 32168767
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Formulation, functional evaluation and ex vivo performance of thermoresponsive soluble gels - A platform for therapeutic delivery to mucosal sinus tissue.
    Pandey P; Cabot PJ; Wallwork B; Panizza BJ; Parekh HS
    Eur J Pharm Sci; 2017 Jan; 96():499-507. PubMed ID: 27771516
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preparation and
    Alami-Milani M; Salatin S; Rayeni FS; Jelvehgari M
    Ther Deliv; 2021 Jun; 12(6):461-475. PubMed ID: 34013779
    [No Abstract]   [Full Text] [Related]  

  • 26. Thermosensitive in situ nanocomposite of rivastigmine hydrogen tartrate as an intranasal delivery system: Development, characterization, ex vivo permeation and cellular studies.
    Salatin S; Barar J; Barzegar-Jalali M; Adibkia K; Jelvehgari M
    Colloids Surf B Biointerfaces; 2017 Nov; 159():629-638. PubMed ID: 28865359
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhanced bioavailability of metoclopramide HCl by intranasal administration of a mucoadhesive in situ gel with modulated rheological and mucociliary transport properties.
    Zaki NM; Awad GA; Mortada ND; Abd Elhady SS
    Eur J Pharm Sci; 2007 Dec; 32(4-5):296-307. PubMed ID: 17920822
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intranasal delivery of ciprofloxacin to rats: A topical approach using a thermoreversible in situ gel.
    Sousa J; Alves G; Oliveira P; Fortuna A; Falcão A
    Eur J Pharm Sci; 2017 Jan; 97():30-37. PubMed ID: 27810560
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel nasal almotriptan loaded solid lipid nanoparticles in mucoadhesive in situ gel formulation for brain targeting: Preparation, characterization and in vivo evaluation.
    Youssef NAHA; Kassem AA; Farid RM; Ismail FA; El-Massik MAE; Boraie NA
    Int J Pharm; 2018 Sep; 548(1):609-624. PubMed ID: 30033394
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development and Evaluation of pH-Responsive Cyclodextrin-Based in situ Gel of Paliperidone for Intranasal Delivery.
    Sherje AP; Londhe V
    AAPS PharmSciTech; 2018 Jan; 19(1):384-394. PubMed ID: 28748368
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Preparation of Cangyi nanoemulsion in situ gel and drug release mechanism of nasal mucosa in vitro].
    Jian-Shuang C; Hao C; Cui-Shan XU; Jie Y; Yong-Yan J
    Zhongguo Zhong Yao Za Zhi; 2020 Sep; 45(17):4211-4220. PubMed ID: 33164406
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In situ gel-forming system: an attractive alternative for nasal drug delivery.
    Wang X; Liu G; Ma J; Guo S; Gao L; Jia Y; Li X; Zhang Q
    Crit Rev Ther Drug Carrier Syst; 2013; 30(5):411-34. PubMed ID: 24099327
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Formulation and Characterization of Nanostructured Lipid Carriers of Rizatriptan Benzoate-Loaded
    Mathure D; Ranpise H; Awasthi R; Pawar A
    Assay Drug Dev Technol; 2022 Jul; 20(5):211-224. PubMed ID: 35771865
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Formulation and Evaluation of Thermoreversible In Situ Nasal Gels Containing Mometasone Furoate for Allergic Rhinitis.
    Altuntaş E; Yener G
    AAPS PharmSciTech; 2017 Oct; 18(7):2673-2682. PubMed ID: 28281209
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development, characterization and application of in situ gel systems for intranasal delivery of tacrine.
    Qian S; Wong YC; Zuo Z
    Int J Pharm; 2014 Jul; 468(1-2):272-82. PubMed ID: 24709220
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development and Evaluation of in-situ Nasal Gel Formulations of Nanosized Transferosomal Sumatriptan: Design, Optimization, in vitro and in vivo Evaluation.
    Omar MM; Eleraky NE; El Sisi AM; Ali Hasan O
    Drug Des Devel Ther; 2019; 13():4413-4430. PubMed ID: 31920290
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of a Thermosensitive In-Situ Gel Formulations of Vancomycin Hydrochloride: Design, Preparation, In Vitro and In Vivo Evaluation.
    Bai L; Lei F; Luo R; Fei Q; Zheng Z; He N; Gui S
    J Pharm Sci; 2022 Sep; 111(9):2552-2561. PubMed ID: 35461804
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased brain radioactivity by intranasal P-labeled siRNA dendriplexes within in situ-forming mucoadhesive gels.
    Perez AP; Mundiña-Weilenmann C; Romero EL; Morilla MJ
    Int J Nanomedicine; 2012; 7():1373-85. PubMed ID: 22457595
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thermo-sensitive gels containing lorazepam microspheres for intranasal brain targeting.
    Jose S; Ansa CR; Cinu TA; Chacko AJ; Aleykutty NA; Ferreira SV; Souto EB
    Int J Pharm; 2013 Jan; 441(1-2):516-26. PubMed ID: 23147411
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Formulation of intranasal mucoadhesive temperature-mediated in situ gel containing ropinirole and evaluation of brain targeting efficiency in rats.
    Khan S; Patil K; Bobade N; Yeole P; Gaikwad R
    J Drug Target; 2010 Apr; 18(3):223-34. PubMed ID: 20030503
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.